Paloma Partners’s Pediatrix Medical MD Stock Holding History

Paloma Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-55,000	Closed	-$1.29M	–	1479
2022 Q1	$1.29M	Buy	+55,000	New	+$1.35M	0.04%	352

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Paloma Partners's MD Position: Q3 2024 in Review

Paloma Partners sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 19,098 shares — an estimated $144K sold.

Paloma Partners first reported a position in MD in Q4 2014 and held it in 19 quarters. The position peaked at $6.88M in Q4 2017. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

Paloma Partners reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
Paloma Partners sold 19,098 Pediatrix Medical shares in Q3 2024, an estimated $144K.
Paloma Partners first reported a position in Pediatrix Medical in Q4 2014 and held it in 19 quarters.
Paloma Partners's Pediatrix Medical position peaked at $6.88M in Q4 2017.
218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.